Your Article Summary
See Latest ArticlesStrong expression of chemokine receptor CXCR4 by renal cell carcinoma correlates with advanced disease
Journal of Oncology, 06/12/09
Wehler TC et al. - In a study to evaluate the influence of CXCR4 expression on the progression of human renal cell carcinoma (RCC), it was shown that strong CXCR4 expression was significantly associated with advanced dedifferentiated RCC.
Methods- CXCR4 expression of RCC was assessed by immunohistochemistry in 113 pts.
- Intensity of CXCR4 expression was correlated with both tumor and pt characteristics.
- Human RCC revealed variable intensities of CXCR4 expression.
- Strong CXCR4 expression of RCC was significantly associated with advanced T-status, tumor dedifferentiation, and low hemoglobin.
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Upfront, randomized, phase II trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma
Cancer, 11/03/09
A Randomized Controlled Study of Weekly and Biweekly Dosing of Epoetin Alfa in CKD Patients With Anemia
Clinical Journal of the American Society of Nephrology, 11/05/09
Anemia and Erythrocytosis After Kidney Transplantation: A 5-Year Graft Function and Survival Analysis
Transplantation Proceedings, 11/11/09